Photo Gallery



News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  • WJPPS Impact Factor
  • Its our Pleasure to Inform you that WJPPS Impact Factor has been increased from  7.454 to 7.632  due to high quality Publication at International Level

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • JUNE 2021 Issue has been successfully launched on 1 June 2021.



Dona Johnson*, Aby Paul, Swapna Saju and Antriya Annie Tom


Background: Snakebite is an occupational hazard leads to morbidity and mortality. Anti-snake venom (ASV) is the only evident treatment option for snake bite envenomation. In India, poly valent anti-venom is the effective antidote against the Big4 category. ASV is manufactured in liquid and lyophilised form. Liquid form can be stored up to 2years whereas lyophilized form can be for 5 years and must be kept in cool temperature. The use of ASV in different hospitals may vary based on the geographical variations. The inventory of different hospitals was compared in this study. Results: The study compares the holding capacity of ASV in different hospitals. There was different brands ASV usage in different hospitals. More than 3 brands were from hospitals 3 and 4. The stock level of ASV is highest for hospital.[4] the increased stock level leads to many problems because ASV is a scare product. The availability is limited. If the stock level increased in some hospitals may leads to scarcity to some other hospitals. The lead time for ASV is similar in hospitals which take nearly 1 month. After 1 month almost all hospitals will move to next stock. The holding quantity of ASV is highest in hospital.[3] The holding quantity depends on different seasons and the hospitals. Excess stock level highest in hospital.[4] As the excess stock increases the wastage as well as the shortage of ASV increases. The excess inventory cost were highest in hospital 4 followed by hospital 1 then hospital.[2] This leads to more economic burden to the hospitals. Conclusion: The hospital burden for ASV treatment was analyzed mainly on the basis of ASV procurement and the use of ASV in different hospitals. It is observed that in most patients more number of ASV vials were used than requirement. This led to high economic burden to the patient. Also the hospital pharmacies included in the study were procuring excess number of ASV than required. Due to improper inventory control measures, hospital burden for storing ASV increases.

Keywords: Snakebite is an occupational hazard leads to morbidity and mortality.

[Full Text Article]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More